Huaren Pharmaceutical Co., Ltd. (300110.SZ) Stock
—
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Ownership
About Huaren Pharmaceutical Co., Ltd.
—
Huaren Pharmaceutical Co., Ltd. is led by CEO Li Zhiyong, employs 2,549 people, headquartered in Qingdao, CN, publicly traded since 2010.
Huaren Pharmaceutical Co., Ltd. (300110.SZ) stock trades at $2.73 with a market capitalization of $3.44B. The stock is valued at a negative price-to-earnings (P/E) ratio of -7.07, reflecting a net loss over the last twelve months, price-to-book of 4.10, price-to-sales of 2.59. Over the past 52 weeks the stock has ranged between $2.41 and $3.98, and currently trades 31.4% below its 52-week high.
On profitability, Huaren Pharmaceutical Co., Ltd. generates a return on equity (ROE) of -39.64% (negative, reflecting a net loss), an operating margin of 10.26%, a net profit margin of -34.86%.
Official website: www.qdhuaren.com
Huaren Pharmaceutical Co., Ltd. (300110.SZ) — frequently asked questions
What is Huaren Pharmaceutical Co., Ltd. (300110.SZ) stock price today?
Huaren Pharmaceutical Co., Ltd. (300110.SZ) is currently trading at $2.73, down 4.21% today.
What is 300110.SZ P/E ratio?
Huaren Pharmaceutical Co., Ltd.'s P/E ratio is -7.07. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.
What is 300110.SZ return on equity (ROE)?
Huaren Pharmaceutical Co., Ltd.'s return on equity (ROE) is -39.64%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.
What is Huaren Pharmaceutical Co., Ltd.'s market cap?
Huaren Pharmaceutical Co., Ltd. has a market capitalization of $3.44B.
Does 300110.SZ pay a dividend?
Huaren Pharmaceutical Co., Ltd. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.
How much debt does 300110.SZ carry?
Huaren Pharmaceutical Co., Ltd. has a debt-to-equity ratio of 0.97. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 300110.SZ's profit margin?
Huaren Pharmaceutical Co., Ltd. reports a net profit margin of -34.86% — the share of revenue left after every cost, including tax and interest.
What sector is 300110.SZ in?
Huaren Pharmaceutical Co., Ltd. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 300110.SZ listed on?
Huaren Pharmaceutical Co., Ltd. trades on SHZ under the ticker 300110.SZ.
What is 300110.SZ's 52-week range?
Over the last year Huaren Pharmaceutical Co., Ltd. has traded between $2.41 and $3.98.
Related — Stocks
Popular Stocks
Screens 300110.SZ currently matches
On the figures above, Huaren Pharmaceutical Co., Ltd. passes the filters for 8 of our ready-made screens, among them Penny Stocks, Stocks Under $5, Stocks Under $10. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.